Ball B, Park J, Proctor E, Brubaker D
bioRxiv. 2024; .
PMID: 39713369
PMC: 11661382.
DOI: 10.1101/2024.12.11.627991.
Figueiredo I, Lima T, Carlstrom P, Assis R, Brunetti I, Baviera A
Nutrients. 2024; 16(11).
PMID: 38892513
PMC: 11173891.
DOI: 10.3390/nu16111580.
Muralidharan C, Huang F, Enriquez J, Wang J, Nelson J, Nargis T
J Clin Invest. 2024; 134(16).
PMID: 38889047
PMC: 11324307.
DOI: 10.1172/JCI176136.
Funsten M, Yurkovetskiy L, Kuznetsov A, Reiman D, Hansen C, Senter K
Cell Host Microbe. 2023; 31(2):213-227.e9.
PMID: 36603588
PMC: 9911364.
DOI: 10.1016/j.chom.2022.12.009.
Sinioja T, Bodin J, Duberg D, Dirven H, Berntsen H, Zimmer K
Metabolomics. 2022; 18(11):87.
PMID: 36329300
PMC: 9633531.
DOI: 10.1007/s11306-022-01945-0.
Short Duration Alagebrium Chloride Therapy Prediabetes Does Not Inhibit Progression to Autoimmune Diabetes in an Experimental Model.
Borg D, Faridi P, Giam K, Reeves P, Fotheringham A, McCarthy D
Metabolites. 2021; 11(7).
PMID: 34203471
PMC: 8305727.
DOI: 10.3390/metabo11070426.
Enhanced insulin receptor interaction by a bifunctional insulin-transferrin fusion protein: an approach to overcome insulin resistance.
Liu Y, Wang H, Shao J, Zaro J, Shen W
Sci Rep. 2020; 10(1):7724.
PMID: 32382087
PMC: 7206000.
DOI: 10.1038/s41598-020-64731-9.
Hepatocellular carcinoma-associated hypercholesterolemia: involvement of proprotein-convertase-subtilisin-kexin type-9 (PCSK9).
Athavale D, Chouhan S, Pandey V, Mayengbam S, Singh S, Bhat M
Cancer Metab. 2018; 6:16.
PMID: 30386595
PMC: 6201570.
DOI: 10.1186/s40170-018-0187-2.
Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice.
Dai Y, Sheng H, Dias P, Rahman M, Bashratyan R, Regn D
Curr Diab Rep. 2017; 17(12):130.
PMID: 29080983
DOI: 10.1007/s11892-017-0962-4.
Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes.
Dooley J, Tian L, Schonefeldt S, Delghingaro-Augusto V, Garcia-Perez J, Pasciuto E
Nat Genet. 2016; 48(5):519-27.
PMID: 26998692
PMC: 5584070.
DOI: 10.1038/ng.3531.
Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model.
Malek Abrahimians E, Vander Elst L, Carlier V, Saint-Remy J
Front Immunol. 2016; 7:67.
PMID: 26973647
PMC: 4773585.
DOI: 10.3389/fimmu.2016.00067.
Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.
Klement R, Fink M
Oncogenesis. 2016; 5:e193.
PMID: 26878387
PMC: 5154349.
DOI: 10.1038/oncsis.2016.2.
The streetlight effect in type 1 diabetes.
Battaglia M, Atkinson M
Diabetes. 2015; 64(4):1081-90.
PMID: 25805758
PMC: 4375074.
DOI: 10.2337/db14-1208.
Cancer as a metabolic disease: implications for novel therapeutics.
Seyfried T, Flores R, Poff A, DAgostino D
Carcinogenesis. 2013; 35(3):515-27.
PMID: 24343361
PMC: 3941741.
DOI: 10.1093/carcin/bgt480.
IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
Diaz-de-Durana Y, Lau J, Knee D, Filippi C, Londei M, McNamara P
PLoS One. 2013; 8(10):e78483.
PMID: 24205242
PMC: 3813455.
DOI: 10.1371/journal.pone.0078483.
Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice.
Rahman M, Regn D, Bashratyan R, Dai Y
Diabetes. 2013; 63(3):1008-20.
PMID: 24170696
PMC: 3931393.
DOI: 10.2337/db13-0859.
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function.
Villalta S, Lang J, Kubeck S, Kabre B, Szot G, Calderon B
Diabetes. 2013; 62(8):2870-8.
PMID: 23835340
PMC: 3717875.
DOI: 10.2337/db12-1619.
Caloric restriction reduces edema and prolongs survival in a mouse glioma model.
Jiang Y, Wang F
J Neurooncol. 2013; 114(1):25-32.
PMID: 23703297
DOI: 10.1007/s11060-013-1154-y.
Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes.
Grant C, Duclos S, Moran-Paul C, Yahalom B, Tirabassi R, Arreaza-Rubin G
Comp Med. 2012; 62(5):381-90.
PMID: 23114041
PMC: 3472602.
The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders.
Arnold I, Hitzler I, Muller A
Front Cell Infect Microbiol. 2012; 2:10.
PMID: 22919602
PMC: 3417532.
DOI: 10.3389/fcimb.2012.00010.